Bison Wealth’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,230
| Closed | -$235K | – | 418 |
|
|
2023
Q4 | $235K | Sell |
1,230
-1,323
| -52% | -$253K | 0.04% | 354 |
|
|
2023
Q3 | $452K | Sell |
2,553
-2,157
| -46% | -$382K | 0.09% | 232 |
|
|
2023
Q2 | $895K | Buy |
4,710
+154
| +3% | +$29.3K | 0.17% | 135 |
|
|
2023
Q1 | $939K | Sell |
4,556
-20
| -0.4% | -$4.12K | 0.29% | 103 |
|
|
2022
Q4 | $1.03M | Sell |
4,576
-1,889
| -29% | -$426K | 0.33% | 97 |
|
|
2022
Q3 | $1.29M | Buy |
+6,465
| New | +$1.29M | 0.51% | 61 |
|